Taltz 00002-8900
Generic: Ixekizumab
Product NDC
00002-8900- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 22, 2016
- Listing Expires
- December 31, 2026
- Application
- BLA125521
Need to source Taltz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ixekizumab | 20 mg/.25mL |
Drug Class
Interleukin-17A Antagonist [EPC]Interleukin-17A Antagonist [EPC]Interleukin-17A Antagonists [MoA]
Packaging Options(1)
1 SYRINGE in 1 CARTON (0002-8900-11) / 1 mL in 1 SYRINGE (0002-8900-01)